DalsnaFinance

Knoa Pharma Board Appoints Michael Goettler as President and Chief Executive Officer

Markets PR Newswire By PR Newswire 01 Jul 2026 18:00 1 min read
Knoa Pharma Board Appoints Michael Goettler as President and Chief Executive Officer

STAMFORD, Conn., July 1, 2026 /PRNewswire/ -- Knoa Pharma today announced the appointment of Michael Goettler as President and Chief Executive Officer, effective July 6. Knoa Pharma, which began operations on May 1, 2026, is a pharmaceutical company driven by a defined public health...

STAMFORD, Conn., July 1, 2026 /PRNewswire/ -- Knoa Pharma today announced the appointment of Michael Goettler as President and Chief Executive Officer, effective July 6. Knoa Pharma, which began operations on May 1, 2026, is a pharmaceutical company driven by a defined public health...

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.